Raja Venkatraman Stock Picks for 8 October: Gland Pharma Above Rs 3,010, Sagility Above Rs 44 and Petronet LNG Above Rs 298, With Targets, Fundamentals, Risks and How to Use Breakout Calls Safely
- October 8, 2026
- Posted by: Harsh Piplani
- Category: News
Venkatraman (NeoTrader): Gland above Rs 3,010 (Rs 3,325), Sagility above Rs 44 (Rs 48.50), Petronet LNG above Rs 298 (Rs 325). No stop-loss stated.
Quick Answer
Raja Venkatraman stock picks name three stocks with breakout triggers: Gland Pharma above Rs 3,010 with a resistance and target zone near Rs 3,325, Sagility above Rs 44 with a target of Rs 48.50 and Petronet LNG above Rs 298 with a target of Rs 325, according to coverage of the NeoTrader co-founder’s call, which was published on 7 October for October and may be updated for 8 October. The triggers are above the recent prices, since Gland Pharma closed near Rs 2,874 on 1 October, Petronet LNG was near Rs 287 in September and Sagility traded near Rs 42 in July, so each call needs the stock to break out before it applies, and the coverage did not state a stop-loss. The fundamentals are strong for Gland and Sagility, with Q1 FY27 profit up 47% and 73.5% year on year, and defensive for Petronet LNG, with record Q1 profit of Rs 1,133 crore, a P/E near 10 and a yield near 3.5%, but each carries risks such as USFDA inspections, client concentration and LNG supply. Use these as technical ideas with a stop-loss and size the position for a volatile market, because the Nifty is near 22,600 and foreign selling continues.
Raja Venkatraman stock picks come from a market where investors weigh a relief rally against persistent foreign selling, and where the Nifty is testing the 22,500 area. Venkatraman is a co-founder of NeoTrader, and these are chart-based ideas and not valuation calls.
If you are weighing the three ideas, this article covers the Raja Venkatraman stock picks with the Rs 3,010 and Rs 3,325 levels for Gland Pharma, Rs 44 and Rs 48.50 for Sagility and Rs 298 and Rs 325 for Petronet LNG, the fundamentals, the USFDA and other risks the coverage flagged, how a breakout call and stop-loss work, a checklist and the market backdrop.
Click Here – Get Free Investment Predictions
Raja Venkatraman Stock Picks: The Levels at a Glance
| Stock | Trigger | Target or resistance | Move from the trigger | Recent price |
|---|---|---|---|---|
| Gland Pharma | Above Rs 3,010 | Rs 3,325 | About 10.5% | About Rs 2,874 on 1 October |
| Sagility | Above Rs 44 | Rs 48.50 | About 10.2% | About Rs 42 on 22 July; check live |
| Petronet LNG | Above Rs 298 | Rs 325 | About 9.1% | About Rs 287 in September |
The coverage of the Raja Venkatraman stock picks describes these as setups for October and gives no stop-loss, so the percentage moves are my calculations from the stated trigger to the target.
Check the Univest Screener for live data on breakout stocks
Raja Venkatraman Stock Picks: Gland Pharma Above Rs 3,010
| Metric | Figure | Note |
|---|---|---|
| Q1 FY27 net profit | About Rs 317 crore, up 47% year on year | Down about 13.6% on the quarter |
| Q1 FY27 revenue | About Rs 1,800 crore | A modest beat on estimates |
| EPS against estimate | Rs 19.22 against Rs 18.03 | A beat of about 6.6% |
| 52-week range | Rs 1,573.60 to Rs 3,042 | The trigger is just below the high |
| Return | About 69% in six months and 44% in a year | Strong momentum |
| Valuation | P/E about 42 times and P/B about 4.6 times | Market cap about Rs 47,400 crore |
| Brokerage view | ICICI Securities valued it at 30 times forward earnings for Rs 3,080 | Below Rs 3,325 |
| Record high | Rs 4,350 in August 2021 | A long way above |
In the Raja Venkatraman stock picks, a move above Rs 3,010 would take Gland past its 52-week high near Rs 3,042, and a target of Rs 3,325 is above the ICICI Securities value of Rs 3,080, so the call relies on momentum more than valuation. Risks the coverage flagged are USFDA inspections and pricing pressure in generic injectables.
Download the Univest iOS App or Univest Android App to track Gland Pharma, Sagility and Petronet LNG live.
Raja Venkatraman Stock Picks: Sagility Above Rs 44
| Metric | Figure | Note |
|---|---|---|
| Q1 FY27 revenue | About Rs 2,024 crore, up 31.5% | $207.8 million, up 27.6% in dollars and about 15% in constant currency |
| Net profit | About Rs 257.7 crore, up 73.5% | Adjusted profit Rs 270 crore, up 35.1% |
| Adjusted EBITDA margin | About 24% | Adjusted EBITDA up about 28% |
| New business | $35.3 million of new annual contract value and 27 new clients | Plus the CareSeed acquisition |
| EPS | Rs 0.56 for the quarter | About 19.6 times on an annualised basis at Rs 44, my calculation |
| Dividend | A first-ever final dividend of Rs 0.10 | Small but a signal |
Among the Raja Venkatraman stock picks, the target of Rs 48.50 is about 10% above the trigger. Sagility is a healthcare business process management company, and the coverage lists operating margin compression and vendor or client concentration as key risks, with one analysis showing net profit down about 16% sequentially in Q1.
Raja Venkatraman Stock Picks: Petronet LNG Above Rs 298
| Metric | Figure | Note |
|---|---|---|
| Q1 FY27 standalone profit | Rs 1,133 crore, up 33% year on year | A record first-quarter profit |
| Revenue | About Rs 5,554 crore | Sequentially lower |
| Volumes | 207 TBTU against 220 TBTU a year ago | Dahej utilisation about 65.6% on expanded capacity |
| Profit driver | Trading and inventory gains from a wide spot to long-term price gap | Not a pure volume story |
| Valuation | P/E about 10 times, yield about 3.5% | Market cap about Rs 43,500 crore |
| Analyst average target | About Rs 317 | One tracker’s 12-month estimate |
| Next results | 5 November 2026 | Per one provider |
Petronet is the defensive pick among the Raja Venkatraman stock picks, with a low P/E and a steady dividend, but global gas pricing and supply disruptions around the Strait of Hormuz can affect volumes.
How to Use Raja Venkatraman Stock Picks Safely
- Treat each level as a breakout trigger and wait for the stock to trade above it, ideally on volume.
- Set your own stop-loss because the coverage did not give one, and size the position so a stop-out is small.
- Do not chase if the stock gaps well above the trigger.
- Check the original post for the exact levels, since the 8 October note may differ from the October levels reported.
- Respect the market: a weak Nifty can break a good chart.
- Use a time frame of days to weeks and review after TCS and other results.
These steps apply to all Raja Venkatraman stock picks and other technical calls, and are general guidance and not advice for you.
Market Backdrop for the Raja Venkatraman Stock Picks
| Measure | Level | Note |
|---|---|---|
| Nifty 50 | 22,603 on 7 October | Near the 22,500 support |
| GIFT Nifty | About 22,557 to 22,601 | A flat to weak open |
| FII flows | Sold Rs 6,121 crore on 7 October | DIIs bought Rs 4,597 crore |
| RBI repo rate | 5.50% | First hike since 2023 |
| US 10-year yield and Brent | About 5.32% and $101 | Headwinds for equities |
Risks Behind the Raja Venkatraman Stock Picks
Breakouts can fail: A move above the trigger can reverse if the market weakens, which would hurt the Raja Venkatraman stock picks.
No stop-loss given: Without a stop, losses in these Raja Venkatraman stock picks can grow beyond what the setup implies.
Stock-specific risks: USFDA action for Gland, client concentration for Sagility and gas supply for Petronet.
Stale price data: Some prices in this article are from recent weeks, so check live data.
Market risk: Yields, oil and foreign selling can overwhelm any single chart.
What to Watch Next for the Raja Venkatraman Stock Picks
- Whether Gland Pharma clears Rs 3,010 and its 52-week high near Rs 3,042.
- Whether Sagility holds above Rs 44 on volume.
- Whether Petronet LNG clears Rs 298 and the Q2 results on 5 November.
- FII and DII flows and the Nifty’s 22,500 support.
- Any update to the levels from NeoTrader.
Conclusion
Raja Venkatraman stock picks give breakout triggers of Rs 3,010 for Gland Pharma, Rs 44 for Sagility and Rs 298 for Petronet LNG, with targets of Rs 3,325, Rs 48.50 and Rs 325 and no stop-loss stated. The fundamentals are solid, but each stock needs the breakout to hold. Consult a SEBI-registered advisor before making any decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Which stocks are in the Raja Venkatraman stock picks?
Ans. The Raja Venkatraman stock picks are Gland Pharma, Sagility and Petronet LNG, as reported from the NeoTrader co-founder’s call.
What are the levels in the Raja Venkatraman stock picks?
Ans. In the Raja Venkatraman stock picks, Gland Pharma is above Rs 3,010 toward Rs 3,325, Sagility above Rs 44 toward Rs 48.50 and Petronet LNG above Rs 298 toward Rs 325.
Is a stop-loss given?
Ans. The coverage of the Raja Venkatraman stock picks that I found does not state one, so set your own.
How strong are Gland Pharma’s results?
Ans. Q1 FY27 profit was about Rs 317 crore, up 47% year on year, and the stock trades near 42 times earnings.
How strong are Sagility’s results?
Ans. Q1 FY27 revenue rose 31.5% to about Rs 2,024 crore and profit rose 73.5% to about Rs 257.7 crore.
Why is Petronet LNG seen as defensive?
Ans. Among the Raja Venkatraman stock picks, it posted record Q1 profit of Rs 1,133 crore, trades near 10 times earnings and yields about 3.5%.
Are these picks for 8 October only?
Ans. The Raja Venkatraman stock picks coverage I found was published on 7 October for October, so check the original post for the 8 October levels.
Should I buy the Raja Venkatraman stock picks?
Ans. This article does not constitute investment advice. Breakout calls can fail. Consult a SEBI-registered financial advisor.
